FPH Stock Overview
Designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Fisher & Paykel Healthcare Corporation Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NZ$38.24 |
| 52 Week High | NZ$39.21 |
| 52 Week Low | NZ$22.55 |
| Beta | 0.38 |
| 1 Month Change | 3.27% |
| 3 Month Change | 1.43% |
| 1 Year Change | 58.67% |
| 3 Year Change | 15.91% |
| 5 Year Change | 70.11% |
| Change since IPO | 8,397.78% |
Recent News & Updates
Recent updates
There May Be Some Bright Spots In Fisher & Paykel Healthcare's (NZSE:FPH) Earnings
Dec 05
The Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Don't Inspire Confidence
Oct 28Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shares May Have Run Too Fast Too Soon
Oct 08Here's Why Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Compensation Is The Least Of Shareholders Concerns
Aug 21Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Jul 29Fisher & Paykel Healthcare (NZSE:FPH) Will Want To Turn Around Its Return Trends
Jul 11Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Investors Are Less Pessimistic Than Expected
Jun 22There May Be Reason For Hope In Fisher & Paykel Healthcare's (NZSE:FPH) Disappointing Earnings
Jun 05Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?
Mar 27Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
Feb 22Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Business Is Yet to Catch Up With Its Share Price
Feb 05Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares Could Be 31% Above Their Intrinsic Value Estimate
Jan 03Shareholder Returns
| FPH | NZ Medical Equipment | NZ Market | |
|---|---|---|---|
| 7D | 3.0% | 1.2% | 0.9% |
| 1Y | 58.7% | 19.5% | 6.1% |
Return vs Industry: FPH exceeded the NZ Medical Equipment industry which returned 19.5% over the past year.
Return vs Market: FPH exceeded the NZ Market which returned 6.1% over the past year.
Price Volatility
| FPH volatility | |
|---|---|
| FPH Average Weekly Movement | 4.0% |
| Medical Equipment Industry Average Movement | 8.7% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in NZ Market | 8.7% |
| 10% least volatile stocks in NZ Market | 3.0% |
Stable Share Price: FPH has not had significant price volatility in the past 3 months compared to the NZ market.
Volatility Over Time: FPH's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1934 | 7,005 | Lewis Gradon | www.fphcare.com |
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation.
Fisher & Paykel Healthcare Corporation Limited Fundamentals Summary
| FPH fundamental statistics | |
|---|---|
| Market cap | NZ$22.42b |
| Earnings (TTM) | NZ$178.50m |
| Revenue (TTM) | NZ$1.89b |
125.6x
P/E Ratio11.9x
P/S RatioIs FPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FPH income statement (TTM) | |
|---|---|
| Revenue | NZ$1.89b |
| Cost of Revenue | NZ$743.30m |
| Gross Profit | NZ$1.15b |
| Other Expenses | NZ$968.50m |
| Earnings | NZ$178.50m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.30 |
| Gross Margin | 60.68% |
| Net Profit Margin | 9.44% |
| Debt/Equity Ratio | 3.5% |
How did FPH perform over the long term?
See historical performance and comparisonDividends
1.1%
Current Dividend Yield137%
Payout RatioDoes FPH pay a reliable dividends?
See FPH dividend history and benchmarks| Fisher & Paykel Healthcare dividend dates | |
|---|---|
| Ex Dividend Date | Dec 05 2024 |
| Dividend Pay Date | Dec 18 2024 |
| Days until Ex dividend | 13 days |
| Days until Dividend pay date | 0 days |
Does FPH pay a reliable dividends?
See FPH dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/17 04:18 |
| End of Day Share Price | 2024/12/17 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Fisher & Paykel Healthcare Corporation Limited is covered by 27 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Russell Wright | APP Securities Pty Ltd. |
| Russell Wright | Barclay Pearce Capital Pty Limited |
| Saul Hadassin | Barrenjoey Markets Pty Limited |